Shares plunged as investors looked past headline numbers and found a troubling reality: the company Coursera bought is masking the fact that its combined business is actually shrinking.
• The Udemy Deal Inflated Revenue, But the Core Business Contracted. Revenue hit $376.7 million, up 94% year-over-year as reported, but normalized revenue — stripping out Udemy's contribution to create an apples-to-apples comparison — fell 3%. The breakdown is stark: enterprise revenue rose just 2% on a normalized basis, while consumer revenue dropped 9%. When a company spends $2.5 billion on an acquisition and the combined entity still can't grow the top line, investors rightly question whether the deal is papering over deeper demand problems. Competitors like Pearson and Duolingo posted healthy growth in their most recent quarters, suggesting Coursera's weakness is company-specific, not an industry-wide issue.
• Cost Cuts Are Running Ahead of Schedule — Because They Have To. Management says it will hit its $115 million annual net synergy target by year-end — just eight months after closing, versus the original 24-month plan.
More than $150 million in annualized gross cost savings are already in place. That sounds impressive, but rapid-fire layoffs and spending reductions are easier to execute than reviving revenue growth. The net synergy figure already bakes in roughly $35 million of expected revenue losses — so-called "dis-synergies" — from customer overlap and marketing pullbacks. Translation: Coursera planned to lose some sales in the merger, and it may be losing more than expected.
• Q4 Guidance Spooked Investors Even More Than Q3 Results. Coursera guided for fourth-quarter revenue of $358–$366 million , reflecting flat enterprise growth and continued consumer deceleration.
An early preview of 2027 pointed to a "meaningfully lower" revenue baseline, triggering analyst downgrades.
The stock began 2026 at $7.36 and has now lost more than half its value.
• A $500 Million Buyback Can't Outrun Shrinking Sales. Coursera repurchased 18.1 million shares for $102 million in Q3 alone, bringing cumulative buybacks past $215 million under a $500 million authorization. Yet the stock keeps falling. Buybacks support the share price only if investors believe in the underlying earnings power. With free cash flow collapsing 83% to just $4.6 million and net losses widening, the aggressive buyback looks more like a confidence signal management is sending to itself than to the market.